Publications by authors named "Elizabeth Sherman"

Claim this Profile
E
Exploring workflows for long-acting antiretroviral therapy administration in community pharmacies.
Valerie Clinard, Kevin Bumanglag, Parya Saberi, Kelly Hester, Michael Sigua, Elizabeth Sherman

J Am Pharm Assoc (2003)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenacapavir: A Twice-Yearly Injectable for HIV Preexposure Prophylaxis.
David E Koren, Elias B Chahine, Elizabeth M Sherman

Ann Pharmacother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting Human Immunodeficiency Virus Syndemic Care in Health Professions Education: Linking Workforce Demands to the Aspirations of a Rising Generation.
Philip Bolduc, Lydia Aoun Barakat, Elizabeth M Sherman, Philip G Day, Tyler Evans

Clin Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of treatment-emergent resistance-associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta-analysis.
Ishfaq Rashid, Nathan R Unger, Connor Willis, Teerapon Dhippayom, Moti Ramgopal, Elizabeth M Sherman

HIV Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global "expiration" of abacavir in adults with HIV: a rapid review of safety and efficacy concerns challenging its role in modern ART.
David B Cluck, Daniel B Chastain, Jacob D Lines, William R Short, Diego Cecchini, Elizabeth M Sherman

Ther Adv Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study.
Jennifer Cocohoba, Yvette Cuca, Elizabeth Sherman, Kelly Hester, George Udeani

BMC Health Serv Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Julia L Marcus, Andrea Weddle, Colleen F Kelley, Allison Agwu, Sheila Montalvo, Elizabeth Sherman

Clin Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists.
Elizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, Georg M N Behrens, Carolyn Chu

Pharmacotherapy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary.
Elizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, Georg M N Behrens, Carolyn Chu

Pharmacotherapy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV.
Marylee W Tailor, Elias B Chahine, David Koren, Elizabeth M Sherman

Ann Pharmacother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalizing prevention: Advances in pharmacotherapy for HIV prevention.
Marisa Brizzi, Elizabeth M Sherman, Sarah B Green, Diana N Nowicki, Emily N Drwiega

Pharmacotherapy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: A case report.
Dor Partosh, Elizabeth M Sherman, Paula A Eckardt, Nathan Unger, Sheila Montalvo

Int J STD AIDS· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of serum leptin at 24-28 weeks gestation with initiation and progression of labor in women.
Ki'ara K R Branham, Elizabeth Sherman, Mojgan Golzy, Erma Z Drobnis, Laura C Schulz

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprint of Implementation of a pharmacist-led ARVSP in an academic hospital to reduce ART errors.
Georandy B Bernard, Sheila Montalvo, Stipe Ivancic, Paula Eckardt, Kenneth Kehn-Yao Poon, Elizabeth M Sherman

J Am Pharm Assoc (2003)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a pharmacist-led ARVSP in an academic hospital to reduce ART errors.
Georandy B Bernard, Sheila Montalvo, Stipe Ivancic, Paula Eckardt, Kenneth Kehn-Yao Poon, Elizabeth M Sherman

J Am Pharm Assoc (2003)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iatrogenic Cushing syndrome following lumbar medial branch block in a patient with HIV on ritonavir and darunavir.
Abhinav Mohan, Steven Tijmes, Jackson Cohen, Elizabeth M Sherman, Paula Eckardt

Pain Manag· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus.
Melissa E Badowski, Nicholas Britt, Emily C Huesgen, Michelle M Lewis, Misty M Miller, Elizabeth Sherman

Pharmacotherapy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection.
Vanessa Huffman, Diana C Andrade, Elizabeth Sherman, Jianli Niu, Paula A Eckardt

Am J Health Syst Pharm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients.
Jason J Schafer, Neha S Pandit, Agnes Cha, Emily Huesgen, Melissa Badowski, Elizabeth M Sherman

Open Forum Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Health Insurance on Hepatitis C Sustained Virologic Response Rates to Sofosbuvir-Based Treatment Regimens in a South Florida Community Hospital.
Paula Eckardt, Jianli Niu, Angela Savage, Tara Griffin, Elizabeth Sherman

J Int Assoc Provid AIDS Care· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of mobile text messages on antiretroviral medication adherence and patient retention in early HIV care: an open-label, randomized, single center study in south Florida.
Elizabeth M Sherman, Jianli Niu, Shara Elrod, Kevin A Clauson, Fadi Alkhateeb

AIDS Res Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Perceptions of Text Messaging to Improve Antiretroviral Therapy Adherence: A Qualitative Study of Patients in a Ryan White Clinic.
Elizabeth Sherman, Kevin Alan Clauson, Shara Elrod, Paula Eckardt, Fadi Alkhateeb

J Int Assoc Provid AIDS Care· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
Kristina M Brooks, Elizabeth M Sherman, Eric F Egelund, Amy Brotherton, Spencer Durham

Pharmacotherapy· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.
Christopher McCoy, Melissa Badowski, Elizabeth Sherman, Rustin Crutchley, Ethan Smith

Pharmacotherapy· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elvitegravir for the treatment of HIV.
Nathan R Unger, Marylee V Worley, Jamie J Kisgen, Elizabeth M Sherman, Lindsey M Childs-Kean

Expert Opin Pharmacother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis